Forbes, one of the world's most authoritative and well-known financial and economic magazines, has published an expert opinion by Nadezhda Kosareva, CEO at Unitsky String Technologies Inc.
The article focuses on the problem of integration of science and business, specializing in the development of high-tech inventions. This publication discusses the difficulties faced by enterprises in building a dialog between these two spheres. In addition, the material emphasizes practical recommendations that will become the basis for the development of scientific direction among high-tech companies.
Read more about the opinion of UST Inc.'s CEO in the article below.
In today's world, it's hard to imagine creating a full-fledged market product from the high-tech sphere without close interaction between business and science.
To withstand competition, companies cannot rely solely on good marketing, modern equipment and sound financial investments; they need innovation. Innovations are what help bypass competitors, occupy a new niche and, therefore, create demand.
As the head of a scientific and engineering company that develops high-tech transportation and infrastructure products, I value the development of the scientific sector as equally essential as other factors like marketing.
Our company has made significant progress in integrating business and science, and I want to share practical recommendations that have made this possible. But first, let's talk about the numbers—they will show how important it is to invest in the science sector.
If you look at the experience of major technology giants, almost all of them use some form of integration between business and science. For example, a record amount of funding for science was recorded in 2022, when 2,500 of the world's largest companies invested about 1.25 trillion euros in research and development. Compared to 2021, this figure increased by 141 billion euros. The ranking of leading countries in terms of R&D expenditures is topped by the U.S.
For example, Apple invested $97.37 billion in research and development between 2018 and 2022. Over the five years, Apple's spending in this segment increased from $14.24 billion in 2018 to $26.25 billion in 2022. According to the company, the R&D investments are meant to differentiate the firm's products and services in the market.
Although the partnership between science and business is strengthening its position in economically developed countries, globally, I see companies' interest in developing scientific direction as still insufficient.
The low involvement of enterprises in scientific activities is caused by a number of factors:
This situation significantly slows down the rapprochement between science and business; when the priority of companies is mainly directed at implementing already created solutions, it jeopardizes the development of new inventions.
The World Intellectual Property Organization's "Global Innovation Index 2023," for example, notes that after a boom in 2021, investment in science and innovation did worse in 2022. There has been little, if any, progress in this area in recent years. Going forward, I believe that continuing along this trajectory could negatively impact business processes.
To prevent this from happening, we need to focus on scientific activity that can help stay ahead of market trends and improve the quality of products. For example, in my company, which develops transport and infrastructure complexes in overpass design, it's important to apply scientific principles to create safer, more efficient and environmentally friendly solutions. When your scientific developments are tested, it gives your product a compelling advantage in the market.
Individual solutions are protected by patents, know-how, as well as by registered and performed R&D. All this builds the credibility of a company and the technologies it creates. At the same time, the increasing pace of scientific achievements and involvement of employees in the scientific sphere help transform promising research results into intangible assets.
The strategic success of the science-business alliance is based on the mutual complementation of competencies. For example, the mandate of scientific activity includes the development of innovations and R&D. Businesses, in turn, coordinate the processes of creation and commercialization of finished products. Ultimately, the integration of the two areas benefits both parties.
If these components work synchronously, high-tech companies can contribute to a unique entrepreneurial environment where business and science go hand in hand. After all, investment in science is not a temporary advantage but a large-scale game for the long term.
This form asks for your consent to allow us to use your personal data for the reasons stated below. You should only sign it if you want to give us your consent.
Who are we?
The name of the organisation asking you for consent to use your information is:
Global Transport Investments
Trident Chambers, P.O. Box 146, Road Town
Tortola
British Virgin Islands
We would like to use the following information about you:
Why would we like to use your information?
Global Transport Investments would like to send this information to company registry, inform you about its news, for refund purposes.
What will we do with your information?
We store your name, address, ID Data, date of birth into company registry. We will share your e-mail & phone number with IT Service (https://digitalcontact.com/), SMS Center (http://smsc.ru). They will add your details to their mailing list and, when it is news update, they will send you an email or sms with details. We store your credit card number for possible refunds.
How to withdraw your consent
You can withdraw the consent you are giving on this form at any time. You can do this by writing to us at the above address, emailing us at the address: [email protected] or by clicking on the unsubscribe link at the bottom of emails you receive.
This privacy notice tells you about the information we collect from you when you sign up to receive our regular newsletter via our website. In collecting this information, we are acting as a data controller and, by law, we are required to provide you with information about us, about why and how we use your data, and about the rights you have over your data.
Who are we?
We are Global Transport Investments. Our address is Trident Chambers, P.O. Box 146, Road Town, Tortola, British Virgin Islands. You can contact us by post at the above address, by email at [email protected].
We are not required to have a data protection officer, so any enquiries about our use of your personal data should be addressed to the contact details above.
What personal data do we collect?
When you subscribe to our newsletter, we ask you for your name and your email address.
Why do we collect this information?
We will use your information to send you our newsletter, which contains information about our products.
We ask for your consent to do this, and we will only send you our newsletter for as long as you continue to consent.
What will we do with your information?
Your information is stored in our database and is shared with with IT Service (https://digitalcontact.com/), SMS Center (http://smsc.ru). It is not sent outside of the Euro. We will not use the information to make any automated decisions that might affect you.
How long do we keep your information for?
Your information is kept for as long as you continue to consent to receive our newsletter.
Your rights over your information
By law, you can ask us what information we hold about you, and you can ask us to correct it if it is inaccurate.
You can also ask for it to be erased and you can ask for us to give you a copy of the information.
You can also ask us to stop using your information – the simplest way to do this is to withdraw your consent, which you can do at any time, either by clicking the unsubscribe link at the end of any newsletter, or by emailing, writing us using the contact details above.
Your right to complain
If you have a complaint about our use of your information, you can contact the Information Commissioner’s Office.
Rate and Comment
You can assess the importance of a particular publication and the level of its preparation. Share your opinion in the comments!